News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,632 Results
Type
Article (89013)
Company Profile (555)
Press Release (797046)
Multimedia
Podcasts (250)
Webinars (37)
Section
Business (267108)
Career Advice (4167)
Deals (40040)
Drug Delivery (182)
Drug Development (91813)
Employer Resources (208)
FDA (18620)
Job Trends (17503)
News (398970)
Policy (40028)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3069)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (213)
Alliances (56991)
ALS (246)
Alzheimer's disease (2052)
Antibody-drug conjugate (ADC) (604)
Approvals (19035)
Artificial intelligence (943)
ASCO (345)
Autoimmune disease (392)
Automation (71)
Bankruptcy (409)
Best Places to Work (12635)
BIO (80)
BIOSECURE Act (23)
Biosimilars (266)
Biotechnology (336)
Bladder cancer (220)
Brain cancer (87)
Breast cancer (874)
Cancer (6915)
Cardiovascular disease (584)
Career advice (3604)
Career pathing (55)
CAR-T (402)
CDC (77)
Celiac Disease (3)
Cell therapy (1123)
Cervical cancer (60)
Clinical research (79540)
Collaboration (2516)
Commercialization (4)
Company closure (8)
Compensation (1624)
Complete response letters (118)
COVID-19 (3047)
CRISPR (130)
C-suite (1403)
Cystic fibrosis (170)
Data (9152)
Decentralized trials (3)
Denatured (96)
Depression (208)
Dermatology (112)
Diabetes (740)
Diagnostics (7696)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (479)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (338)
Earnings (102749)
Editorial (81)
Employer branding (25)
Employer resources (178)
Events (139157)
Executive appointments (1251)
FDA (22973)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (37)
Funding (2053)
Gene editing (285)
Generative AI (95)
Gene therapy (883)
GLP-1 (1306)
Government (5574)
Grass and pollen (8)
Guidances (429)
Healthcare (21283)
Hematology (198)
HIV (107)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (372)
Immuno-oncology (124)
Indications (231)
Infectious disease (3463)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (343)
Interviews (823)
IPO (18023)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (27)
Labor market (130)
Layoffs (699)
Leadership (56)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (916)
Lymphoma (498)
Machine learning (70)
Management (69)
Manufacturing (1331)
Marketing (10)
MASH (233)
Medical affairs (1)
Medical device (15335)
Medtech (15548)
Mergers & acquisitions (23402)
Metabolic disorders (1904)
mRNA (283)
Multiple sclerosis (217)
NASH (24)
Neurodegenerative disease (553)
Neuropsychiatric disorders (133)
Neuroscience (3907)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5150)
Now hiring (85)
Obesity (902)
Opinion (385)
Ovarian cancer (257)
Pain (300)
Pancreatic cancer (379)
Parkinson's disease (434)
Partnered (43)
Patents (704)
Patient recruitment (856)
Peanut (72)
People (68292)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24567)
Phase 2 (34544)
Phase 3 (25984)
Pipeline (10704)
Policy (409)
Postmarket research (3561)
Preclinical (11018)
Press Release (72)
Prostate cancer (367)
Psychedelics (82)
Radiopharmaceuticals (388)
Rare diseases (1365)
Real estate (7467)
Recruiting (83)
Regulatory (30828)
Reports (78)
Research institute (2782)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (200)
Series A (351)
Series B (254)
Service/supplier (15)
Sickle cell disease (135)
Special edition (33)
Spinal muscular atrophy (193)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (154)
Tariffs (104)
The Weekly (151)
Vaccines (1343)
Venture capital (144)
Weight loss (611)
Women's health (150)
Worklife (25)
Date
Today (17)
Last 7 days (491)
Last 30 days (2005)
Last 365 days (33295)
2026 (19259)
2025 (33213)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1299)
Alabama (106)
Alaska (7)
Arizona (419)
Arkansas (16)
Asia (52526)
Australia (9234)
California (14916)
Canada (4177)
China (1696)
Colorado (642)
Connecticut (657)
Delaware (462)
Europe (121119)
Florida (2249)
Georgia (485)
Hawaii (4)
Idaho (70)
Illinois (1308)
India (114)
Indiana (688)
Iowa (25)
Japan (640)
Kansas (146)
Kentucky (58)
Louisiana (64)
Maine (92)
Maryland (1792)
Massachusetts (10892)
Michigan (430)
Minnesota (832)
Mississippi (7)
Missouri (170)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3947)
New Mexico (36)
New York (3938)
North Carolina (1973)
North Dakota (11)
Northern California (7466)
Ohio (469)
Oklahoma (29)
Oregon (46)
Pennsylvania (2913)
Puerto Rico (33)
Rhode Island (54)
South America (1671)
South Carolina (92)
South Dakota (2)
Southern California (5890)
Tennessee (243)
Texas (2424)
United States (53248)
Utah (449)
Vermont (2)
Virginia (375)
Washington D.C. (88)
Washington State (1209)
West Virginia (4)
Wisconsin (166)
Wyoming (2)
There are 886,632 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
July 27, 2026
·
7 min read
Press Releases
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
July 27, 2026
·
1 min read
Press Releases
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older
July 27, 2026
·
11 min read
Press Releases
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth
July 27, 2026
·
4 min read
Press Releases
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 24, 2026
July 27, 2026
·
2 min read
Press Releases
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
July 27, 2026
·
3 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - July 24, 2026
July 27, 2026
·
1 min read
Press Releases
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
July 27, 2026
·
6 min read
CAR-T
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
Safety will be the key determinant of in vivo CAR T therapies, according to H.C. Wainwright’s Mitchel Kapoor, who noted that convenience and efficacy won’t be enough to impress investors in this space. Eli Lilly, AbbVie, AstraZeneca and more are up for the challenge.
July 27, 2026
·
8 min read
·
Tristan Manalac
China
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
Summit Therapeutics revealed positive Western data last week from a Phase 3 trial of lung cancer candidate ivonescimab. In a flipped geographical clinical trials landscape, what more will be required for Summit and China-based partner Akeso—and other transnational tandems—to secure FDA approval?
July 27, 2026
·
10 min read
·
Heather McKenzie
1 of 88,664
Next
